Tabuteau; Herriot

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tabuteau; Herriot.The latest application filed is for "bupropion as a modulator of drug activity".

Company Profile

152.200.200

Tabuteau; Herriot - New York NY
- New York NY US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bupropion as a modulator of drug activity Grant 11,439,636 - Tabuteau September 13, 2	2022-09-13
Bupropion As A Modulator Of Drug Activity App 20220280504 - Tabuteau; Herriot	2022-09-08
Reboxetine To Treat Narcolepsy App 20220280524 - Tabuteau; Herriot	2022-09-08
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 11,433,035 - Tabuteau September 6, 2	2022-09-06
Bupropion as a modulator of drug activity Grant 11,433,067 - Tabuteau September 6, 2	2022-09-06
Pharmaceutical compositions comprising meloxicam Grant 11,433,079 - Tabuteau September 6, 2	2022-09-06
Pharmaceutical compositions comprising meloxicam Grant 11,433,078 - Tabuteau September 6, 2	2022-09-06
Bupropion as a modulator of drug activity Grant 11,426,401 - Tabuteau August 30, 2	2022-08-30
Pharmaceutical compositions comprising meloxicam Grant 11,426,414 - Tabuteau August 30, 2	2022-08-30
Bupropion as a modulator of drug activity Grant 11,426,370 - Tabuteau August 30, 2	2022-08-30
Bupropion as a modulator of drug activity Grant 11,419,867 - Tabuteau August 23, 2	2022-08-23
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20220257538 - Tabuteau; Herriot	2022-08-18
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20220249406 - Tabuteau; Herriot	2022-08-11
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20220249405 - Tabuteau; Herriot	2022-08-11
Use Of Esreboxetine To Treat Nervous System Disorders Such As Fibromyalgia App 20220249501 - Tabuteau; Herriot	2022-08-11
Bupropion As A Modulator Of Drug Activity App 20220241221 - Tabuteau; Herriot	2022-08-04
Bupropion As A Modulator Of Drug Activity App 20220241270 - Tabuteau; Herriot	2022-08-04
Bupropion As A Modulator Of Drug Activity App 20220241269 - Tabuteau; Herriot	2022-08-04
Pharmaceutical Compositions Comprising Meloxicam App 20220241292 - Tabuteau; Herriot	2022-08-04
Bupropion As A Modulator Of Drug Activity App 20220241220 - Tabuteau; Herriot	2022-08-04
Bupropion As A Modulator Of Drug Activity App 20220233474 - Tabuteau; Herriot	2022-07-28
Bupropion As A Modulator Of Drug Activity App 20220233519 - Tabuteau; Herriot	2022-07-28
Bupropion As A Modulator Of Drug Activity App 20220233518 - Tabuteau; Herriot	2022-07-28
Pharmaceutical Compositions Comprising Meloxicam App 20220233698 - Tabuteau; Herriot	2022-07-28
Bupropion As A Modulator Of Drug Activity App 20220233470 - Tabuteau; Herriot	2022-07-28
Bupropion As A Modulator Of Drug Activity App 20220218631 - Tabuteau; Herriot	2022-07-14
Bupropion As A Modulator Of Drug Activity App 20220218698 - Tabuteau; Herriot	2022-07-14
Pharmaceutical Compositions Comprising Meloxicam App 20220218718 - Tabuteau; Herriot	2022-07-14
Bupropion as a modulator of drug activity Grant 11,382,874 - Tabuteau July 12, 2	2022-07-12
Pharmaceutical Compositions Comprising Meloxicam App 20220211851 - Tabuteau; Herriot	2022-07-07
Pharmaceutical compositions comprising meloxicam Grant 11,369,684 - Tabuteau June 28, 2	2022-06-28
Bupropion As A Modulator Of Drug Activity App 20220193012 - Tabuteau; Herriot	2022-06-23
Methods Of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion App 20220193009 - Tabuteau; Herriot	2022-06-23
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20220193011 - Tabuteau; Herriot	2022-06-23
Bupropion as a modulator of drug activity Grant 11,364,233 - Tabuteau June 21, 2	2022-06-21
Use of reboxetine to treat narcolepsy Grant 11,364,245 - Tabuteau June 21, 2	2022-06-21
Bupropion as a modulator of drug activity Grant 11,357,744 - Tabuteau June 14, 2	2022-06-14
Pharmaceutical compositions comprising meloxicam Grant 11,357,854 - Tabuteau June 14, 2	2022-06-14
Pharmaceutical Compositions Comprising Meloxicam App 20220175927 - Tabuteau; Herriot	2022-06-09
Pharmaceutical Compositions Comprising Meloxicam App 20220175792 - Tabuteau; Herriot	2022-06-09
Use of reboxetine to treat narcolepsy Grant 11,351,175 - Tabuteau June 7, 2	2022-06-07
Bupropion as a modulator of drug activity Grant 11,344,544 - Tabuteau May 31, 2	2022-05-31
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 11,344,514 - Tabuteau May 31, 2	2022-05-31
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 11,344,513 - Tabuteau May 31, 2	2022-05-31
Pharmaceutical compositions comprising meloxicam Grant 11,331,323 - Tabuteau May 17, 2	2022-05-17
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 11,331,285 - Tabuteau May 17, 2	2022-05-17
Bupropion As A Modulator Of Drug Activity App 20220142950 - Tabuteau; Herriot	2022-05-12
Bupropion As A Modulator Of Drug Activity App 20220133655 - Tabuteau; Herriot	2022-05-05
Bupropion as a modulator of drug activity Grant 11,311,534 - Tabuteau April 26, 2	2022-04-26
Bupropion as a modulator of drug activity Grant 11,298,352 - Tabuteau April 12, 2	2022-04-12
Bupropion as a modulator of drug activity Grant 11,298,351 - Tabuteau April 12, 2	2022-04-12
Bupropion As A Modulator Of Drug Activity App 20220105086 - Tabuteau; Herriot	2022-04-07
Pharmaceutical Compositions Comprising Meloxicam App 20220105104 - Tabuteau; Herriot	2022-04-07
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 11,291,639 - Tabuteau April 5, 2	2022-04-05
Bupropion as a modulator of drug activity Grant 11,291,665 - Tabuteau April 5, 2	2022-04-05
Bupropion as a modulator of drug activity Grant 11,291,638 - Tabuteau April 5, 2	2022-04-05
Pharmaceutical Compositions Comprising Meloxicam App 20220096490 - Tabuteau; Herriot	2022-03-31
Bupropion As A Modulator Of Drug Activity App 20220096462 - Tabuteau; Herriot	2022-03-31
Pharmaceutical compositions comprising meloxicam Grant 11,285,213 - Tabuteau March 29, 2	2022-03-29
Bupropion as a modulator of drug activity Grant 11,285,118 - Tabuteau March 29, 2	2022-03-29
Bupropion as a modulator of drug activity Grant 11,285,146 - Tabuteau March 29, 2	2022-03-29
Pharmaceutical compositions comprising meloxicam Grant 11,285,215 - Tabuteau March 29, 2	2022-03-29
Pharmaceutical compositions comprising meloxicam Grant 11,285,214 - Tabuteau March 29, 2	2022-03-29
Pharmaceutical Compositions Comprising Meloxicam App 20220088027 - Tabuteau; Herriot	2022-03-24
Bupropion As A Modulator Of Drug Activity App 20220079892 - Tabuteau; Herriot	2022-03-17
Bupropion as a modulator of drug activity Grant 11,273,133 - Tabuteau March 15, 2	2022-03-15
Bupropion as a modulator of drug activity Grant 11,273,134 - Tabuteau March 15, 2	2022-03-15
Bupropion As A Modulator Of Drug Activity App 20220071931 - Tabuteau; Herriot	2022-03-10
Bupropion As A Modulator Of Drug Activity App 20220071930 - Tabuteau; Herriot	2022-03-10
Pharmaceutical compositions comprising meloxicam Grant 11,266,657 - Tabuteau March 8, 2	2022-03-08
Bupropion As A Modulator Of Drug Activity App 20220062275 - Tabuteau; Herriot	2022-03-03
Pharmaceutical Compositions Comprising Meloxicam App 20220054498 - Tabuteau; Herriot	2022-02-24
Bupropion as a modulator of drug activity Grant 11,253,492 - Tabuteau February 22, 2	2022-02-22
Bupropion as a modulator of drug activity Grant 11,253,491 - Tabuteau February 22, 2	2022-02-22
Bupropion As A Modulator Of Drug Activity App 20220031691 - Tabuteau; Herriot	2022-02-03
Bupropion as a modulator of drug activity Grant 11,234,946 - Tabuteau February 1, 2	2022-02-01
Methods Of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion App 20220023234 - Tabuteau; Herriot	2022-01-27
Combination of dextromethorphan and bupropion for treating depression Grant 11,229,640 - Tabuteau January 25, 2	2022-01-25
Bupropion As A Modulator Of Drug Activity App 20220008363 - Tabuteau; Herriot	2022-01-13
Pharmaceutical Compositions Comprising Meloxicam App 20220008539 - Tabuteau; Herriot	2022-01-13
Pharmaceutical compositions comprising meloxicam Grant 11,219,626 - Tabuteau January 11, 2	2022-01-11
Bupropion as a modulator of drug activity Grant 11,213,521 - Tabuteau January 4, 2	2022-01-04
Bupropion As A Modulator Of Drug Activity App 20210401830 - Tabuteau; Herriot	2021-12-30
Pharmaceutical Compositions Comprising Meloxicam App 20210401988 - Tabuteau; Herriot	2021-12-30
Bupropion As A Modulator Of Drug Activity App 20210401831 - Tabuteau; Herriot	2021-12-30
Bupropion As A Modulator Of Drug Activity App 20210401829 - Tabuteau; Herriot	2021-12-30
Bupropion As A Modulator Of Drug Activity App 20210401828 - Tabuteau; Herriot	2021-12-30
Pharmaceutical compositions comprising meloxicam Grant 11,207,327 - Tabuteau December 28, 2	2021-12-28
Bupropion as a modulator of drug activity Grant 11,207,281 - Tabuteau December 28, 2	2021-12-28
Pharmaceutical compositions comprising meloxicam Grant 11,207,328 - Tabuteau December 28, 2	2021-12-28
Pharmaceutical Compositions Comprising Meloxicam App 20210393782 - Tabuteau; Herriot	2021-12-23
Bupropion as a modulator of drug activity Grant 11,197,839 - Tabuteau December 14, 2	2021-12-14
Combination Of Dextromethorphan And Bupropion For Treating Depression App 20210379054 - Tabuteau; Herriot	2021-12-09
Bupropion as a modulator of drug activity Grant 11,191,739 - Tabuteau December 7, 2	2021-12-07
Pharmaceutical Compositions Comprising Meloxicam App 20210369729 - Tabuteau; Herriot	2021-12-02
Pharmaceutical Compositions Comprising Meloxicam App 20210369845 - Tabuteau; Herriot	2021-12-02
Use Of Reboxetine To Treat Narcolepsy App 20210369722 - Tabuteau; Herriot	2021-12-02
Pharmaceutical compositions comprising meloxicam Grant 11,185,550 - Tabuteau November 30, 2	2021-11-30
Use of reboxetine to treat narcolepsy Grant 11,185,547 - Tabuteau November 30, 2	2021-11-30
Bupropion as a modulator of drug activity Grant 11,185,515 - Tabuteau November 30, 2	2021-11-30
Pharmaceutical Compositions Comprising Meloxicam App 20210361667 - Tabuteau; Herriot	2021-11-25
Bupropion As A Modulator Of Drug Activity App 20210361645 - Tabuteau; Herriot	2021-11-25
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 11,179,352 - Tabuteau November 23, 2	2021-11-23
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 11,179,351 - Tabuteau November 23, 2	2021-11-23
Pharmaceutical Compositions Comprising Meloxicam App 20210353636 - Tabuteau; Herriot	2021-11-18
Pharmaceutical Compositions Comprising Meloxicam App 20210346393 - Tabuteau; Herriot	2021-11-11
Bupropion As A Modulator Of Drug Activity App 20210346370 - Tabuteau; Herriot	2021-11-11
Bupropion As A Modulator Of Drug Activity App 20210338605 - Tabuteau; Herriot	2021-11-04
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20210330613 - Tabuteau; Herriot	2021-10-28
Pharmaceutical Compositions Comprising Meloxicam App 20210322552 - Tabuteau; Herriot	2021-10-21
Method of decreasing the fluctuation index of dextromethorphan Grant 11,147,808 - Tabuteau October 19, 2	2021-10-19
Bupropion as a modulator of drug activity Grant 11,141,416 - Tabuteau October 12, 2	2021-10-12
Bupropion as a modulator of drug activity Grant 11,141,388 - Tabuteau October 12, 2	2021-10-12
Use of reboxetine to treat narcolepsy Grant 11,135,226 - Tabuteau October 5, 2	2021-10-05
Pharmaceutical compositions comprising meloxicam Grant 11,135,295 - Tabuteau October 5, 2	2021-10-05
Pharmaceutical compositions comprising meloxicam Grant 11,129,895 - Tabuteau September 28, 2	2021-09-28
Bupropion as a modulator of drug activity Grant 11,129,826 - Tabuteau September 28, 2	2021-09-28
Bupropion as a modulator of drug activity Grant 11,123,342 - Tabuteau September 21, 2	2021-09-21
Bupropion as a modulator of drug activity Grant 11,123,344 - Tabuteau September 21, 2	2021-09-21
Pharmaceutical compositions comprising meloxicam Grant 11,123,431 - Tabuteau September 21, 2	2021-09-21
Bupropion as a modulator of drug activity Grant 11,123,343 - Tabuteau September 21, 2	2021-09-21
Pharmaceutical Compositions Comprising Meloxicam App 20210275670 - Tabuteau; Herriot	2021-09-09
Pharmaceutical compositions comprising meloxicam Grant 11,110,173 - Tabuteau September 7, 2	2021-09-07
Bupropion As A Modulator Of Drug Activity App 20210267967 - Tabuteau; Herriot	2021-09-02
Bupropion As A Modulator Of Drug Activity App 20210260054 - Tabuteau; Herriot	2021-08-26
Pharmaceutical Compositions Comprising Meloxicam App 20210260194 - Tabuteau; Herriot	2021-08-26
Pharmaceutical Compositions Comprising Meloxicam App 20210260193 - Tabuteau; Herriot	2021-08-26
Bupropion as a modulator of drug activity Grant 11,096,937 - Tabuteau August 24, 2	2021-08-24
Use Of Reboxetine To Treat Narcolepsy App 20210252007 - Tabuteau; Herriot	2021-08-19
Bupropion as a modulator of drug activity Grant 11,090,300 - Tabuteau August 17, 2	2021-08-17
Pharmaceutical compositions comprising meloxicam Grant 11,077,117 - Tabuteau August 3, 2	2021-08-03
Pharmaceutical Compositions Comprising Meloxicam App 20210228592 - Tabuteau; Herriot	2021-07-29
Bupropion As A Modulator Of Drug Activity App 20210220294 - Tabuteau; Herriot	2021-07-22
Bupropion As A Modulator Of Drug Activity App 20210220348 - Tabuteau; Herriot	2021-07-22
Bupropion As A Modulator Of Drug Activity App 20210220293 - Tabuteau; Herriot	2021-07-22
Bupropion as a modulator of drug activity Grant 11,065,248 - Tabuteau July 20, 2	2021-07-20
Bupropion as a modulator of drug activity Grant 11,058,648 - Tabuteau July 13, 2	2021-07-13
Bupropion As A Modulator Of Drug Activity App 20210205240 - Tabuteau; Herriot	2021-07-08
Bupropion As A Modulator Of Drug Activity App 20210205297 - Tabuteau; Herriot	2021-07-08
Bupropion As A Modulator Of Drug Activity App 20210205239 - Tabuteau; Herriot	2021-07-08
Bupropion As A Modulator Of Drug Activity App 20210196705 - Tabuteau; Herriot	2021-07-01
Pharmaceutical Compositions Comprising Meloxicam App 20210196726 - Tabuteau; Herriot	2021-07-01
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20210196704 - Tabuteau; Herriot	2021-07-01
Pharmaceutical compositions comprising meloxicam Grant 11,045,549 - Tabuteau June 29, 2	2021-06-29
Bupropion As A Modulator Of Drug Activity App 20210186956 - Tabuteau; Herriot	2021-06-24
Bupropion As A Modulator Of Drug Activity App 20210186901 - Tabuteau; Herriot	2021-06-24
Bupropion As A Modulator Of Drug Activity App 20210186899 - Tabuteau; Herriot	2021-06-24
Bupropion As A Modulator Of Drug Activity App 20210186900 - Tabuteau; Herriot	2021-06-24
Bupropion As A Modulator Of Drug Activity App 20210186955 - Tabuteau; Herriot	2021-06-24
Pharmaceutical Compositions Comprising Meloxicam App 20210177971 - Tabuteau; Herriot	2021-06-17
Pharmaceutical Compositions Comprising Meloxicam App 20210177972 - Tabuteau; Herriot	2021-06-17
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20210177834 - Tabuteau; Herriot	2021-06-17
Use Of Reboxetine To Treat Narcolepsy App 20210169893 - Tabuteau; Herriot	2021-06-10
Use of reboxetine to treat narcolepsy Grant 11,020,402 - Tabuteau June 1, 2	2021-06-01
Bupropion as a modulator of drug activity Grant 11,020,389 - Tabuteau June 1, 2	2021-06-01
Pharmaceutical compositions comprising meloxicam Grant 11,020,483 - Tabuteau June 1, 2	2021-06-01
Pharmaceutical Compositions Comprising Meloxicam App 20210154299 - Tabuteau; Herriot	2021-05-27
Pharmaceutical compositions comprising meloxicam Grant 11,013,806 - Tabuteau May 25, 2	2021-05-25
Pharmaceutical compositions comprising meloxicam Grant 11,013,805 - Tabuteau May 25, 2	2021-05-25
Methods Of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion App 20210145770 - Tabuteau; Herriot	2021-05-20
Bupropion as a modulator of drug activity Grant 11,007,189 - Tabuteau May 18, 2	2021-05-18
Pharmaceutical Compositions Comprising Meloxicam App 20210128576 - Tabuteau; Herriot	2021-05-06
Pharmaceutical Compositions Comprising Meloxicam App 20210128575 - Tabuteau; Herriot	2021-05-06
Pharmaceutical Compositions Comprising Meloxicam App 20210121474 - Tabuteau; Herriot	2021-04-29
Pharmaceutical compositions comprising meloxicam Grant 10,987,358 - Tabuteau April 27, 2	2021-04-27
Bupropion as a modulator of drug activity Grant 10,980,800 - Tabuteau April 20, 2	2021-04-20
Bupropion As A Modulator Of Drug Activity App 20210106546 - Tabuteau; Herriot	2021-04-15
Use Of Reboxetine To Treat Narcolepsy App 20210100809 - Tabuteau; Herriot	2021-04-08
Use Of Reboxetine To Treat Narcolepsy App 20210100808 - Tabuteau; Herriot	2021-04-08
Bupropion as a modulator of drug activity Grant 10,966,941 - Tabuteau April 6, 2	2021-04-06
Bupropion as a modulator of drug activity Grant 10,966,942 - Tabuteau April 6, 2	2021-04-06
Bupropion as a modulator of drug activity Grant 10,966,974 - Tabuteau April 6, 2	2021-04-06
Bupropion As A Modulator Of Drug Activity App 20210077428 - Tabuteau; Herriot	2021-03-18
Bupropion As A Modulator Of Drug Activity App 20210077429 - Tabuteau; Herriot	2021-03-18
Bupropion As A Modulator Of Drug Activity App 20210077483 - Tabuteau; Herriot	2021-03-18
Bupropion as a modulator of drug activity Grant 10,945,973 - Tabuteau March 16, 2	2021-03-16
Bupropion As A Modulator Of Drug Activity App 20210069125 - Tabuteau; Herriot	2021-03-11
Bupropion As A Modulator Of Drug Activity App 20210069128 - Tabuteau; Herriot	2021-03-11
Bupropion as a modulator of drug activity Grant 10,940,124 - Tabuteau March 9, 2	2021-03-09
Pharmaceutical compositions comprising meloxicam Grant 10,940,153 - Tabuteau March 9, 2	2021-03-09
Bupropion As A Modulator Of Drug Activity App 20210060005 - Tabuteau; Herriot	2021-03-04
Bupropion As A Modulator Of Drug Activity App 20210060004 - Tabuteau; Herriot	2021-03-04
Bupropion as a modulator of drug activity Grant 10,933,034 - Tabuteau March 2, 2	2021-03-02
Pharmaceutical compositions comprising meloxicam Grant 10,933,136 - Tabuteau March 2, 2	2021-03-02
Pharmaceutical compositions comprising meloxicam Grant 10,933,137 - Tabuteau March 2, 2	2021-03-02
Bupropion As A Modulator Of Drug Activity App 20210052521 - Tabuteau; Herriot	2021-02-25
Bupropion as a modulator of drug activity Grant 10,925,842 - Tabuteau February 23, 2	2021-02-23
Bupropion As A Modulator Of Drug Activity App 20210046067 - Tabuteau; Herriot	2021-02-18
Pharmaceutical compositions comprising meloxicam Grant 10,918,722 - Tabuteau February 16, 2	2021-02-16
Pharmaceutical Compositions Comprising Meloxicam App 20210030876 - Tabuteau; Herriot	2021-02-04
Bupropion As A Modulator Of Drug Activity App 20210030747 - Tabuteau; Herriot	2021-02-04
Bupropion As A Modulator Of Drug Activity App 20210030751 - Tabuteau; Herriot	2021-02-04
Bupropion As A Modulator Of Drug Activity App 20210030750 - Tabuteau; Herriot	2021-02-04
Bupropion As A Modulator Of Drug Activity App 20210030749 - Tabuteau; Herriot	2021-02-04
Pharmaceutical compositions comprising meloxicam Grant 10,905,693 - Tabuteau February 2, 2	2021-02-02
Bupropion As A Modulator Of Drug Activity App 20210023076 - Tabuteau; Herriot	2021-01-28
Bupropion As A Modulator Of Drug Activity App 20210023075 - Tabuteau; Herriot	2021-01-28
Bupropion as a modulator of drug activity Grant 10,898,453 - Tabuteau January 26, 2	2021-01-26
Bupropion As A Modulator Of Drug Activity App 20210015768 - Tabuteau; Herriot	2021-01-21
Compositions For Delivery Of Reboxetine App 20210015823 - Tabuteau; Herriot	2021-01-21
Bupropion As A Modulator Of Drug Activity App 20210015815 - Tabuteau; Herriot	2021-01-21
Bupropion As A Modulator Of Drug Activity App 20210015814 - Tabuteau; Herriot	2021-01-21
Bupropion as a modulator of drug activity Grant 10,894,046 - Tabuteau January 19, 2	2021-01-19
Bupropion as a modulator of drug activity Grant 10,894,047 - Tabuteau January 19, 2	2021-01-19
Pharmaceutical compositions comprising meloxicam Grant 10,894,053 - Tabuteau January 19, 2	2021-01-19
Pharmaceutical Compositions Comprising Meloxicam App 20210008211 - Tabuteau; Herriot	2021-01-14
Bupropion As A Modulator Of Drug Activity App 20210000763 - Tabuteau; Herriot	2021-01-07
Bupropion As A Modulator Of Drug Activity App 20210000768 - Tabuteau; Herriot	2021-01-07
Pharmaceutical Compositions Comprising Meloxicam App 20210000956 - Tabuteau; Herriot	2021-01-07
Bupropion As A Modulator Of Drug Activity App 20210000820 - Tabuteau; Herriot	2021-01-07
Bupropion As A Modulator Of Drug Activity App 20210000765 - Tabuteau; Herriot	2021-01-07
Bupropion As A Modulator Of Drug Activity App 20210000764 - Tabuteau; Herriot	2021-01-07
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,881,624 - Tabuteau January 5, 2	2021-01-05
Bupropion as a modulator of drug activity Grant 10,881,657 - Tabuteau January 5, 2	2021-01-05
Bupropion As A Modulator Of Drug Activity App 20200405664 - Tabuteau; Herriot	2020-12-31
Pharmaceutical Compositions Comprising Meloxicam App 20200405861 - Tabuteau; Herriot	2020-12-31
Pharmaceutical Compositions Comprising Meloxicam App 20200405862 - Tabuteau; Herriot	2020-12-31
Bupropion as a modulator of drug activity Grant 10,874,664 - Tabuteau December 29, 2	2020-12-29
Bupropion as a modulator of drug activity Grant 10,874,665 - Tabuteau December 29, 2	2020-12-29
Bupropion as a modulator of drug activity Grant 10,874,663 - Tabuteau December 29, 2	2020-12-29
Bupropion As A Modulator Of Drug Activity App 20200397724 - Tabuteau; Herriot	2020-12-24
Bupropion As A Modulator Of Drug Activity App 20200397723 - Tabuteau; Herriot	2020-12-24
Bupropion as a modulator of drug activity Grant 10,864,209 - Tabuteau December 15, 2	2020-12-15
Pharmaceutical Compositions Comprising Meloxicam App 20200376125 - Tabuteau; Herriot	2020-12-03
Pharmaceutical Compositions Comprising Meloxicam App 20200376124 - Tabuteau; Herriot	2020-12-03
Bupropion As A Modulator Of Drug Activity App 20200360310 - Tabuteau; Herriot	2020-11-19
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200345664 - Tabuteau; Herriot	2020-11-05
Methods Of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion App 20200345663 - Tabuteau; Herriot	2020-11-05
Pharmaceutical compositions comprising meloxicam Grant 10,821,182 - Tabuteau November 3, 2	2020-11-03
Pharmaceutical compositions comprising meloxicam Grant 10,821,181 - Tabuteau November 3, 2	2020-11-03
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200338021 - Tabuteau; Herriot	2020-10-29
Bupropion As A Modulator Of Drug Activity App 20200338022 - Tabuteau; Herriot	2020-10-29
Pharmaceutical Compositions Comprising Meloxicam App 20200338198 - Tabuteau; Herriot	2020-10-29
Bupropion and dextromethorphan for treating nicotine addiction Grant 10,813,924 - Tabuteau October 27, 2	2020-10-27
Pharmaceutical Compositions Comprising Meloxicam App 20200330476 - Tabuteau; Herriot	2020-10-22
Bupropion as a modulator of drug activity Grant 10,806,710 - Tabuteau October 20, 2	2020-10-20
Combination of dextromethorphan and bupropion for treating depression Grant 10,799,497 - Tabuteau October 13, 2	2020-10-13
Pharmaceutical compositions comprising meloxicam Grant 10,799,588 - Tabuteau October 13, 2	2020-10-13
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200315992 - Tabuteau; Herriot	2020-10-08
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,786,469 - Tabuteau September 29, 2	2020-09-29
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,786,496 - Tabuteau September 29, 2	2020-09-29
Bupropion As A Modulator Of Drug Activity App 20200297666 - Tabuteau; Herriot	2020-09-24
Bupropion as a modulator of drug activity Grant 10,780,064 - Tabuteau Sept	2020-09-22
Pharmaceutical compositions comprising meloxicam Grant 10,780,165 - Tabuteau Sept	2020-09-22
Pharmaceutical compositions comprising meloxicam Grant 10,780,166 - Tabuteau Sept	2020-09-22
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,780,066 - Tabuteau Sept	2020-09-22
Pharmaceutical Compositions Comprising Meloxicam App 20200289524 - Tabuteau; Herriot	2020-09-17
Bupropion as a modulator of drug activity Grant 10,772,850 - Tabuteau Sept	2020-09-15
Pharmaceutical Compositions Comprising Meloxicam App 20200276311 - Tabuteau; Herriot	2020-09-03
Pharmaceutical compositions comprising meloxicam Grant 10,758,617 - Tabuteau Sep	2020-09-01
Pharmaceutical compositions comprising meloxicam Grant 10,758,618 - Tabuteau Sep	2020-09-01
Pharmaceutical Compositions Comprising Meloxicam App 20200261467 - Tabuteau; Herriot	2020-08-20
Pharmaceutical Compositions Comprising Meloxicam App 20200261466 - Tabuteau; Herriot	2020-08-20
Bupropion As A Modulator Of Drug Activity App 20200261431 - Tabuteau; Herriot	2020-08-20
Pharmaceutical Compositions Comprising Meloxicam App 20200254097 - Kind Code	2020-08-13
Pharmaceutical Compositions Comprising Meloxicam App 20200246461 - Kind Code	2020-08-06
Pharmaceutical Compositions Comprising Meloxicam App 20200246462 - Kind Code	2020-08-06
Bupropion As A Modulator Of Drug Activity App 20200246280 - Kind Code	2020-08-06
Pharmaceutical compositions comprising meloxicam Grant 10,729,697 - Tabuteau	2020-08-04
Pharmaceutical compositions comprising meloxicam Grant 10,729,773 - Tabuteau	2020-08-04
Pharmaceutical compositions comprising meloxicam Grant 10,729,696 - Tabuteau	2020-08-04
Pharmaceutical compositions comprising meloxicam Grant 10,729,774 - Tabuteau	2020-08-04
Bupropion As A Modulator Of Drug Activity App 20200237751 - Tabuteau; Herriot	2020-07-30
Bupropion As A Modulator Of Drug Activity App 20200237752 - Tabuteau; Herriot	2020-07-30
Pharmaceutical compositions comprising meloxicam Grant 10,722,583 - Tabuteau	2020-07-28
Bupropion As A Modulator Of Drug Activity App 20200230130 - Tabuteau; Herriot	2020-07-23
Pharmaceutical Compositions Comprising Meloxicam App 20200230239 - Tabuteau; Herriot	2020-07-23
Bupropion As A Modulator Of Drug Activity App 20200230129 - Tabuteau; Herriot	2020-07-23
Bupropion As A Modulator Of Drug Activity App 20200230078 - Tabuteau; Herriot	2020-07-23
Bupropion As A Modulator Of Drug Activity App 20200230131 - Tabuteau; Herriot	2020-07-23
Pharmaceutical Compositions Comprising Meloxicam App 20200230240 - Tabuteau; Herriot	2020-07-23
Pharmaceutical Compositions Comprising Meloxicam App 20200230241 - Tabuteau; Herriot	2020-07-23
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200222339 - Tabuteau; Herriot	2020-07-16
Bupropion As A Modulator Of Drug Activity App 20200222388 - Tabuteau; Herriot	2020-07-16
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200222342 - Tabuteau; Herriot	2020-07-16
Bupropion As A Modulator Of Drug Activity App 20200222389 - Tabuteau; Herriot	2020-07-16
Pharmaceutical Compositions Comprising Meloxicam App 20200222539 - Tabuteau; Herriot	2020-07-16
Bupropion As A Modulator Of Drug Activity App 20200215058 - Tabuteau; Herriot	2020-07-09
Bupropion As A Modulator Of Drug Activity App 20200215059 - Tabuteau; Herriot	2020-07-09
Bupropion As A Modulator Of Drug Activity App 20200215057 - Tabuteau; Herriot	2020-07-09
Bupropion As A Modulator Of Drug Activity App 20200215056 - Tabuteau; Herriot	2020-07-09
Bupropion As A Modulator Of Drug Activity App 20200215055 - Tabuteau; Herriot	2020-07-09
Pharmaceutical compositions comprising meloxicam Grant 10,702,602 - Tabuteau	2020-07-07
Pharmaceutical compositions comprising meloxicam Grant 10,702,535 - Tabuteau	2020-07-07
Bupropion And Dextromethorphan For Treating Nicotine Addiction App 20200206217 - Tabuteau; Herriot	2020-07-02
Pharmaceutical compositions comprising meloxicam Grant 10,695,429 - Tabuteau	2020-06-30
Pharmaceutical compositions comprising meloxicam Grant 10,695,430 - Tabuteau	2020-06-30
Dosage forms and methods for enantiomerically enriched or pure bupropion Grant 10,695,304 - Tabuteau	2020-06-30
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200197333 - Tabuteau; Herriot	2020-06-25
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200197331 - Tabuteau; Herriot	2020-06-25
Bupropion and dextromethorphan for treating nicotine addiction Grant 10,688,066 - Tabuteau	2020-06-23
Pharmaceutical compositions comprising meloxicam Grant 10,688,185 - Tabuteau	2020-06-23
Combination treatment for migraine and other pain Grant 10,688,102 - Tabuteau	2020-06-23
Pharmaceutical Compositions Comprising Meloxicam App 20200179396 - Tabuteau; Herriot	2020-06-11
Pharmaceutical Compositions Comprising Meloxicam App 20200155565 - Tabuteau; Herriot	2020-05-21
Pharmaceutical compositions comprising meloxicam Grant 10,653,777 - Tabuteau	2020-05-19
Use Of Esreboxetine To Treat Nervous System Disorders Such As Fibromyalgia App 20200147095 - Tabuteau; Herriot	2020-05-14
Use Of Esreboxetine To Treat Nervous System Disorders Such As Fibromyalgia App 20200147096 - Tabuteau; Herriot	2020-05-14
Combination Of Dextromethorphan And Bupropion For Treating Depression App 20200147075 - Tabuteau; Herriot	2020-05-14
Bupropion And Dextromethorphan For Treating Nicotine Addiction App 20200147008 - Tabuteau; Herriot	2020-05-14
Use Of Reboxetine To Treat Narcolepsy App 20200147094 - Tabuteau; Herriot	2020-05-14
Use Of Esreboxetine To Treat Nervous System Disorders Such As Fibromyalgia App 20200147093 - Tabuteau; Herriot	2020-05-14
Compositions And Methods For Increasing The Metabolic Lifetime Of Dextromethorphan And Related Pharmacodynamic Effects App 20200093762 - Tabuteau; Herriot	2020-03-26
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200093761 - Tabuteau; Herriot	2020-03-26
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20200093760 - Tabuteau; Herriot	2020-03-26
Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan Grant 10,596,167 - Tabuteau	2020-03-24
Pharmaceutical Compositions Comprising Meloxicam App 20200085953 - Tabuteau; Herriot	2020-03-19
Pharmaceutical Compositions Comprising Meloxicam App 20200085954 - Tabuteau; Herriot	2020-03-19
Pharmaceutical Compositions Comprising Meloxicam App 20200085952 - Tabuteau; Herriot	2020-03-19
Pharmaceutical Compositions Comprising Meloxicam App 20200085951 - Tabuteau; Herriot	2020-03-19
Pharmaceutical Compositions Comprising Meloxicam App 20200085955 - Tabuteau; Herriot	2020-03-19
Pharmaceutical compositions comprising meloxicam Grant 10,583,088 - Tabuteau	2020-03-10
Pharmaceutical compositions comprising meloxicam Grant 10,583,144 - Tabuteau	2020-03-10
Pharmaceutical compositions comprising meloxicam Grant 10,561,664 - Tabuteau Feb	2020-02-18
Pharmaceutical Compositions Comprising Meloxicam App 20200038408 - Tabuteau; Herriot	2020-02-06
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,548,857 - Tabuteau Fe	2020-02-04
Pharmaceutical Compositions Comprising Meloxicam App 20200030338 - Tabuteau; Herriot	2020-01-30
Bupropion As A Modulator Of Drug Activity App 20200022929 - Tabuteau; Herriot	2020-01-23
Pharmaceutical compositions comprising meloxicam Grant 10,537,642 - Tabuteau Ja	2020-01-21
Pharmaceutical compositions comprising meloxicam Grant 10,532,101 - Tabuteau Ja	2020-01-14
Pharmaceutical Compositions Comprising Meloxicam App 20200009250 - Tabuteau; Herriot	2020-01-09
Pharmaceutical Compositions Comprising Meloxicam App 20200000921 - Tabuteau; Herriot	2020-01-02
Pharmaceutical Compositions Comprising Meloxicam App 20200000922 - Tabuteau; Herriot	2020-01-02
Pharmaceutical Compositions Comprising Meloxicam App 20200000920 - Tabuteau; Herriot	2020-01-02
Pharmaceutical Compositions Comprising Meloxicam App 20200000819 - Tabuteau; Herriot	2020-01-02
Pharmaceutical Compositions Comprising Meloxicam App 20200000820 - Tabuteau; Herriot	2020-01-02
Pharmaceutical Compositions Comprising Meloxicam App 20200000919 - Tabuteau; Herriot	2020-01-02
Pharmaceutical compositions comprising meloxicam Grant 10,517,950 - Tabuteau Dec	2019-12-31
Pharmaceutical compositions comprising meloxicam Grant 10,512,692 - Tabuteau Dec	2019-12-24
Pharmaceutical compositions comprising meloxicam Grant 10,512,693 - Tabuteau Dec	2019-12-24
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,512,643 - Tabuteau Dec	2019-12-24
Compositions For Delivery Of Reboxetine App 20190381056 - Tabuteau; Herriot	2019-12-19
Methods Of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion App 20190374521 - Tabuteau; Herriot	2019-12-12
Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases Grant 10,493,085 - Tabuteau De	2019-12-03
Pharmaceutical compositions comprising meloxicam Grant 10,485,871 - Tabuteau Nov	2019-11-26
Pharmaceutical compositions comprising meloxicam Grant 10,471,069 - Tabuteau Nov	2019-11-12
Pharmaceutical compositions comprising meloxicam Grant 10,471,014 - Tabuteau Nov	2019-11-12
Pharmaceutical compositions comprising meloxicam Grant 10,471,068 - Tabuteau Nov	2019-11-12
Combination Treatment For Migraine And Other Pain App 20190336510 - Tabuteau; Herriot	2019-11-07
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,463,634 - Tabuteau No	2019-11-05
Pharmaceutical compositions comprising meloxicam Grant 10,463,736 - Tabuteau No	2019-11-05
Compositions for oral administration of zoledronic acid or related compounds for treating low back pain Grant 10,463,682 - Tabuteau No	2019-11-05
Pharmaceutical compositions comprising meloxicam Grant 10,456,471 - Tabuteau Oc	2019-10-29
Compositions For Oral Administration Of Zoledronic Acid Or Related Compounds For Treating Disease App 20190314391 - Tabuteau; Herriot	2019-10-17
Pharmaceutical Compositions Comprising Meloxicam App 20190314504 - Tabuteau; Herriot	2019-10-17
Pharmaceutical Compositions Comprising Meloxicam App 20190307884 - Tabuteau; Herriot	2019-10-10
Pharmaceutical compositions comprising meloxicam Grant 10,426,839 - Tabuteau October 1, 2	2019-10-01
Neridronic Acid And Other Bisphosphonates For Treating Complex Regional Pain Syndrome And Other Diseases App 20190290665A1 -	2019-09-26
Bupropion And Dextromethorphan For Treating Nicotine Addiction App 20190290601A1 -	2019-09-26
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190290664 - Tabuteau; Herriot	2019-09-26
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease Grant 10,420,782 - Tabuteau Sept	2019-09-24
Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases Grant 10,413,561 - Tabuteau Sept	2019-09-17
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease Grant 10,413,560 - Tabuteau Sept	2019-09-17
Pharmaceutical Compositions Comprising Meloxicam App 20190255177A1 -	2019-08-22
Pharmaceutical compositions comprising meloxicam Grant 10,369,224 - Tabuteau	2019-08-06
Pharmaceutical compositions comprising meloxicam Grant 10,369,225 - Tabuteau	2019-08-06
Pharmaceutical Compositions Comprising Meloxicam App 20190231792A1 -	2019-08-01
Pharmaceutical compositions comprising meloxicam Grant 10,363,312 - Tabuteau	2019-07-30
Pharmaceutical Compositions Comprising Meloxicam App 20190224321A1 -	2019-07-25
Pharmaceutical Compositions Comprising Meloxicam App 20190224320A1 -	2019-07-25
Bupropion As A Modulator Of Drug Activity App 20190216798A1 -	2019-07-18
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20190216800A1 -	2019-07-18
Neridronic Acid And Other Bisphosphonates For Treating Complex Regional Pain Syndrome And Other Diseases App 20190216728A1 -	2019-07-18
Neridronic Acid And Other Bisphosphonates For Treating Complex Regional Pain Syndrome And Other Diseases App 20190216833A1 -	2019-07-18
Dosage Forms And Methods For Enantiomerically Enriched Or Pure Bupropion App 20190216801A1 -	2019-07-18
Neridronic Acid And Other Bisphosphonates For Treating Complex Regional Pain Syndrome And Other Diseases App 20190216832A1 -	2019-07-18
Neridronic acid for treating complex regional pain syndrome Grant 10,350,227 - Tabuteau July 16, 2	2019-07-16
Compositions for oral administration of zoledronic acid or related compounds for treating disease Grant 10,335,424 - Tabuteau	2019-07-02
Bupropion As A Modulator Of Drug Activity App 20190192450A1 -	2019-06-27
Bupropion As A Modulator Of Drug Activity App 20190192507A1 -	2019-06-27
Pharmaceutical compositions comprising meloxicam Grant 10,322,181 - Tabuteau	2019-06-18
Compositions For Oral Administration Of Zoledronic Acid Or Related Compounds For Treating Disease App 20190167703A1 -	2019-06-06
Pharmaceutical compositions comprising meloxicam Grant 10,307,484 - Tabuteau	2019-06-04
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190160080A1 -	2019-05-30
Pharmaceutical Compositions Comprising Meloxicam App 20190142942A1 -	2019-05-16
Pharmaceutical Compositions Comprising Meloxicam App 20190142943A1 -	2019-05-16
Bupropion As A Modulator Of Drug Activity App 20190142768A1 -	2019-05-16
Compositions For Oral Administration Of Zoledronic Acid Or Related Compounds For Treating Disease App 20190117677A1 -	2019-04-25
Pharmaceutical compositions comprising meloxicam Grant 10,265,324 - Tabuteau	2019-04-23
Compositions for oral administration of zoledronic acid or related compounds for treating disease Grant 10,265,332 - Tabuteau	2019-04-23
Pharmaceutical compositions comprising meloxicam Grant 10,265,400 - Tabuteau	2019-04-23
Pharmaceutical compositions comprising meloxicam Grant 10,265,399 - Tabuteau	2019-04-23
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190111065A1 -	2019-04-18
Bupropion as a modulator of drug activity Grant 10,251,879 - Tabuteau	2019-04-09
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190099434A1 -	2019-04-04
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190091143A1 -	2019-03-28
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease Grant 10,238,672 - Tabuteau	2019-03-26
Compositions And Methods For Increasing The Metabolic Lifetime Of Dextromethorphan And Related Pharmacodynamic Effects App 20190083426A1 -	2019-03-21
Pharmaceutical Compositions Comprising Meloxicam App 20190070192A1 -	2019-03-07
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190054099A1 -	2019-02-21
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease Grant 10,195,141 - Tabuteau Fe	2019-02-05
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease Grant 10,195,223 - Tabuteau Fe	2019-02-05
Pharmaceutical compositions comprising meloxicam Grant 10,195,279 - Tabuteau Fe	2019-02-05
Pharmaceutical compositions comprising meloxicam Grant 10,195,278 - Tabuteau Fe	2019-02-05
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190030052A1 -	2019-01-31
Dosage Forms For Oral Administration Of Zoledronic Acid Or Related Compounds For Treating Disease App 20190030051A1 -	2019-01-31
Neridronic Acid For Treating Complex Regional Pain Syndrome App 20190030050A1 -	2019-01-31
Dosage Forms For Oral Administration Of Zoledronic Acid Or Related Compounds For Treating Disease App 20190023661A1 -	2019-01-24
Dosage Forms For Oral Administration Of Zoledronic Acid Or Related Compounds For Treating Disease App 20190015434A1 -	2019-01-17
Compositions And Methods Comprising Bupropion Or Related Compounds For Sustained Delivery Of Dextromethorphan App 20190015407A1 -	2019-01-17
Bupropion And Dextromethorphan For Treating Nicotine Addiction App 20190008805A1 -	2019-01-10
Compositions And Methods For Increasing The Metabolic Lifetime Of Dextromethorphan And Related Pharmacodynamic Effects App 20190008801A1 -	2019-01-10
Compositions And Methods For Increasing The Metabolic Lifetime Of Dextromethorphan And Related Pharmacodynamic Effects App 20190008800A1 -	2019-01-10
Methods for the safe administration of imidazole or imidazolium compounds Grant 10,173,986 - Tabuteau J	2019-01-08
Compositions For Oral Administration Of Zoledronic Acid Or Related Compounds For Treating Disease App 20190000864A1 -	2019-01-03
Bupropion As A Modulator Of Drug Activity App 20190000835A1 -	2019-01-03
Pharmaceutical Compositions Comprising Meloxicam App 20190000975A1 -	2019-01-03
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease Grant 10,137,139 - Tabuteau November 27, 2	2018-11-27
Pharmaceutical compositions comprising meloxicam Grant 10,137,131 - Tabuteau November 27, 2	2018-11-27
Neridronic acid for treating complex regional pain syndrome Grant 10,117,880 - Tabuteau November 6, 2	2018-11-06
Dosage forms for oral administration of zoledronic acid or related compounds for treating disease Grant 10,111,894 - Tabuteau October 30, 2	2018-10-30
Compositions for oral administration of zoledronic acid or related compounds for treating disease Grant 10,111,891 - Tabuteau October 30, 2	2018-10-30
Dosage forms for oral administration of zoledronic acid or related compounds Grant 10,111,837 - Tabuteau October 30, 2	2018-10-30
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,105,361 - Tabuteau October 23, 2	2018-10-23
Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects Grant 10,105,327 - Tabuteau October 23, 2	2018-10-23
Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan Grant 10,092,561 - Tabuteau October 9, 2	2018-10-09
Osteoclast inhibitors such as zoledronic acid for low back pain treatment Grant 10,092,581 - Tabuteau , et al. October 9, 2	2018-10-09
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,092,560 - Tabuteau October 9, 2	2018-10-09
Neridronic acid for treating complex regional pain syndrome Grant 10,080,765 - Tabuteau September 25, 2	2018-09-25
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 10,080,727 - Tabuteau September 25, 2	2018-09-25
Bupropion as a modulator of drug activity Grant 10,064,857 - Tabuteau September 4, 2	2018-09-04
Bupropion as a modulator of drug activity Grant 10,058,518 - Tabuteau August 28, 2	2018-08-28
Pharmaceutical compositions comprising meloxicam Grant 10,058,614 - Tabuteau August 28, 2	2018-08-28
Neridronic acid for treating complex regional pain syndrome Grant 10,052,338 - Tabuteau August 21, 2	2018-08-21
Neridronic acid for treating complex regional pain syndrome Grant 10,039,774 - Tabuteau August 7, 2	2018-08-07
Neridronic acid for treating arthritis Grant 10,039,773 - Tabuteau August 7, 2	2018-08-07
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome Grant 10,034,890 - Tabuteau July 31, 2	2018-07-31
Pharmaceutical compositions comprising meloxicam Grant 10,029,010 - Tabuteau July 24, 2	2018-07-24
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome Grant 10,028,908 - Tabuteau July 24, 2	2018-07-24
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome Grant 10,028,969 - Tabuteau July 24, 2	2018-07-24
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome Grant 10,016,445 - Tabuteau July 10, 2	2018-07-10
Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone Grant 10,016,446 - Tabuteau July 10, 2	2018-07-10
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome Grant 10,004,756 - Tabuteau June 26, 2	2018-06-26
Neridronic acid for treating complex regional pain syndrome Grant 9,999,628 - Tabuteau June 19, 2	2018-06-19
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome Grant 9,999,629 - Tabuteau June 19, 2	2018-06-19
Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects Grant 9,968,568 - Tabuteau May 15, 2	2018-05-15
Osteoclast inhibitors for joint conditions Grant 9,956,234 - Tabuteau May 1, 2	2018-05-01
Bupropion As A Modulator Of Drug Activity App 20160375008A1 -	2016-12-29
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects App 20160375012A1 -	2016-12-29

Company Registrations

SEC

0001219927

TABUTEAU HERRIOT